☆ 4.3 Article

Improving Risk Management by Learning from Adverse Events: Report on One Year of COVID-19 Vaccination Campaign in Verona (Northeastern Italy)

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Risk mapping associated with organization of a COVID-19 immunization campaign

S. Le Tohic et al.

Summary: The study aims to map the major risks associated with the organization of a COVID-19 immunization campaign and proposes action plans for optimization.

ANNALES PHARMACEUTIQUES FRANCAISES (2022)

Add to Collection
Review Medicine, General & Internal

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Olivier J. Wouters et al.

Summary: The COVID-19 pandemic may not end globally until vaccines that protect against severe disease and drive herd immunity are widely distributed. While vaccines have been authorized for human use in many countries, achieving global control of COVID-19 requires not only licensed vaccines but also mass production, affordable pricing, global allocation, and wide local deployment.

LANCET (2021)

Add to Collection
Editorial Material Public, Environmental & Occupational Health

The largest vaccination campaign in history: A golden opportunity for bundling public health interventions

Moosa Tatar et al.

JOURNAL OF GLOBAL HEALTH (2021)

Add to Collection
Article Immunology

A Comparison of Vaccine Hesitancy of COVID-19 Vaccination in China and the United States

Taoran Liu et al.

Summary: High acceptance rates of COVID-19 vaccination were observed in both China and the United States, but differences exist between the two countries. Chinese respondents are more concerned about adverse effects of vaccines, while respondents from the U.S. prioritize vaccine efficacy and cost.

VACCINES (2021)

Add to Collection
Article Immunology

Using Failure Mode, Effect and Criticality Analysis to Improve Safety in the COVID Mass Vaccination Campaign

Alessandra Buja et al.

Summary: Vaccination against SARS-CoV-2 is a promising way to combat the pandemic, but it should be supported by appropriate patient safety management. A study using FMECA analyzed potential failures in the mass vaccination process and identified high-risk failure modes with recommended actions to prevent their occurrence or improve detection. The application of FMECA in mass vaccination is crucial for identifying and mitigating potential risks in this high-risk process.

VACCINES (2021)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.